- Home
- HOWL vs LSBK Comparison
HOWL vs LSBK Comparison
Compare HOWL & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- LSBK
- Stock Information
- Founded
- HOWL 2017
- LSBK 1891
- Country
- HOWL United States
- LSBK United States
- Employees
- HOWL N/A
- LSBK N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- LSBK Savings Institutions
- Sector
- HOWL Health Care
- LSBK Finance
- Exchange
- HOWL Nasdaq
- LSBK Nasdaq
- Market Cap
- HOWL 62.4M
- LSBK 90.3M
- IPO Year
- HOWL 2021
- LSBK 2006
- Fundamental
- Price
- HOWL $1.21
- LSBK $16.25
- Analyst Decision
- HOWL Strong Buy
- LSBK
- Analyst Count
- HOWL 3
- LSBK 0
- Target Price
- HOWL $9.00
- LSBK N/A
- AVG Volume (30 Days)
- HOWL 242.3K
- LSBK 5.5K
- Earning Date
- HOWL 03-11-2025
- LSBK 04-21-2025
- Dividend Yield
- HOWL N/A
- LSBK 4.57%
- EPS Growth
- HOWL N/A
- LSBK 7.32
- EPS
- HOWL N/A
- LSBK 0.88
- Revenue
- HOWL $1,885,000.00
- LSBK $25,846,000.00
- Revenue This Year
- HOWL $36.45
- LSBK N/A
- Revenue Next Year
- HOWL $296.58
- LSBK N/A
- P/E Ratio
- HOWL N/A
- LSBK $17.92
- Revenue Growth
- HOWL N/A
- LSBK N/A
- 52 Week Low
- HOWL $1.03
- LSBK $10.30
- 52 Week High
- HOWL $6.89
- LSBK $16.95
- Technical
- Relative Strength Index (RSI)
- HOWL 40.43
- LSBK 60.75
- Support Level
- HOWL $1.18
- LSBK $15.63
- Resistance Level
- HOWL $1.30
- LSBK $16.70
- Average True Range (ATR)
- HOWL 0.10
- LSBK 0.31
- MACD
- HOWL 0.00
- LSBK -0.06
- Stochastic Oscillator
- HOWL 47.37
- LSBK 63.89
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.